5-(4-Chlorophenyl)-2-methoxypyrimidine

Catalog No.: 
ACTPKY189
CAS No.: 
27956-14-5
Molecular Formula: 
C11H9ClN2O
Molecular Weight: 
220.66
5-(4-Chlorophenyl)-2-methoxypyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(4-Chlorophenyl)-2-methoxypyrimidine
IUPAC Name5-(4-chlorophenyl)-2-methoxypyrimidine
Molecular FormulaC11H9ClN2O
Molecular Weight220.66
SMILESCOC1=NC=C(C2=CC=C(Cl)C=C2)C=N1
InChI KeyNZDVLOVMSQNWJZ-UHFFFAOYSA-N
SynonymPyrimidine, 5-(4-chlorophenyl)-2-methoxy-
CAS No.27956-14-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTPKY189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVMHY731 route compound structure diagram
    ACVMHY73114001-66-2In Stock
  2. Plus
  3. ACHZRV039 route compound structure diagram
    ACHZRV0391679-18-1In Stock
  4. Then
  5. ACTPKY189 route product structure diagram
    ACTPKY18927956-14-5
Inquiry

2. ACTPKY189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJIPZ019 route compound structure diagram
    ACJIPZ019101803-06-9In Stock
  2. Plus
  3. ACHZRV039 route compound structure diagram
    ACHZRV0391679-18-1In Stock
  4. Then
  5. ACTPKY189 route product structure diagram
    ACTPKY18927956-14-5
Inquiry

3. ACTPKY189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACEOWQ681 route compound structure diagram
    ACEOWQ68127956-40-7In Stock
  4. Then
  5. ACTPKY189 route product structure diagram
    ACTPKY18927956-14-5
Inquiry

Comments (0)